I am...
A financial adviser / intermediary contact An existing investor with Montgomery

IS THERE STILL JUICE IN THE TELSTRA THESIS?

GIVEN TELSTRA’S RECENT SHARE PRICE APPRECIATION, DOES IT STILL LOOK LIKE AN ATTRACTIVE INVESTMENT PROPOSITION?

TIM KELLEY SHARES HIS VIEW IN THIS PIECE FOR LIVEWIRE AND ALSO IDENTIFIES ONE COMPANY WHICH THE MARKET IS OVEREMPHASISING THE DOWNSIDE AND IGNORING THE UPSIDE.

READ HERE

WE BELIEVE IN THE POTENTIAL OF SMALL COMPANIES

WE RECENTLY PARTICIPATED IN THE IPO OF MONEYME.
FOUNDED IN 2013, MONEYME HAS OFFERED MORE THAN
$340 MILLION IN LOANS UP TO $25,000 TO MORE THAN 80,000
CUSTOMERS ACROSS AUSTRALIA.

A GROWTH STORY THAT PASSED OUR IPO FILTERS.

FIND OUT MORE

Our Private Office

Montgomery’s Private Office focuses on the best vehicles and strategies for investments starting from $1 million.

ENTER

How Can We Help You Invest?

{{flashMessage}}


You might like to read more about these...

{{fund.title}}

Find Out More

Any advice provided on this website is of a general nature only and does not take into account your personal needs, objectives and financial circumstances. You should consider whether it is appropriate for your situation. Consider the product disclosure statement before making an investment decision. Please read our Financial Services Guide for more information.

Discover Montgomery

Montgomery manages value-oriented funds focused on ownership of high quality businesses and generating superior returns over the long term. Read more about our investment approach.

Explore
More Articles

Investor Insights & Media

February 10, 2020

Why there’s no stopping CSL’s charge to the top

By Roger Montgomery

Since listing in 1994, Australian biotech company CSL has powered ahead to become our second largest company by market cap. Lying just ahead is the Commonwealth Bank. But with a more compelling growth story, it’s probably just a matter of when, not if, CSL will hit the front.
Read Article
Share
February 7, 2020

A Montgomery reporting season preview

By Roger Montgomery

With reporting season about to commence amid the bush fires and coronavirus, the environment is ripe for more positive and negative surprises than we have seen in some time. Meanwhile the ASX 200 industrial index, excluding financials, is trading on a record PE of 28. 5 times.
Read Article
Share

New to Investing

Read our knowledge-based articles to learn the basics of investing.

Learn More

Current Montgomery Investors

Visit our dedicated investors centre for log in details, forms and statements.

Access Here

Ask a Question

Join our live chat or contact us to speak with us directly.

Contact Us
Close

Our Funds

Concentrated High Conviction Equities

Listed

Montgomery Global Equities Fund (ASX:MOGL)

Global
Available on the ASX as an Exchange Traded Managed Fund, invests in 15 to 30 quality global businesses for long-term capital growth with a target distribution yield of 4.5% per annum. Mirrors the strategy of the Montgomery Global Fund.
Learn More
Unlisted From $25,000

Montgomery Global Fund

Global
Invests in 15 to 30 quality global businesses for long-term capital growth. Priced daily. Mirrors the strategy of the Montgomery Global Equities Fund (ASX:MOGL).
Learn More
Unlisted from $25,000

The Montgomery Fund

Australia/NZ
Aims to provide long-term growth and income by investing in 20 to 40 high-quality Australian and New Zealand businesses trading at attractive valuations. Priced daily.
Learn More
New Fund

Montgomery Small Companies Fund

Australia/NZ
Aims to provide long-term growth by investing in 30 to 50 high quality, undervalued, Australian and NZ small and emerging companies with strong growth potential. Priced daily.
Learn More
Unlisted from $1 Million

The Montgomery [Private] Fund

Australia/NZ
Seeks to deliver absolute returns from a portfolio of high-quality Australian and New Zealand businesses. Capital preservation is paramount. By invitation only.
Learn More

Alternate Equity Strategies

Unlisted from $50,000

Montgomery Alpha Plus Fund

Global
Aims to generate positive returns in both rising and falling markets. Invests in 80 to 180 global businesses expected to deliver above-average returns, while selling short a similar-sized portfolio expected to deliver below-average returns. Priced daily.
Learn More
Unlisted from $50,000

Montaka Global Access Fund

Global
Aims to generate materially higher risk-adjusted returns, net of fees, than is generally available in the equities market over the medium term. Priced monthly. Provides retail investors access to the Montaka Global Fund.
Learn More
Unlisted from $1million

Montaka Global 130/30 Fund

Global
Provides the opportunity to benefit from both the gains of extraordinary businesses and the declines of deteriorating businesses through a global equity active extension strategy, which has the potential to significantly outperform the broader equities market over time. Seeks to generate double-digit annual average returns, net of fees. Daily priced.
Learn More
Unlisted From $1 Million

Montaka Global Fund

Global
Aims to generate materially higher risk-adjusted returns, net of fees, than is generally available in the equities market over the medium term. By invitation only.
Learn More